BIT 0.00% 1.9¢ biotron limited

chart weekly, page-1656

  1. 498 Posts.
    lightbulb Created with Sketch. 944
    One more day has passed..

    It has now been the 10th successful replication, continuously, of the first trial where the efficacy of BIT225 against SAR-CoV-2 was tested. The trial, without a doubt, has demonstrated a 99% reduction of SAR-CoV-2 in infected Vero/hSLAM cells culture, as confirmed by RT-PCR.

    MM glances at ASX contact number, and then stares into space, deep in thought.
    Someone interrupted: "Should we make an announcement"?
    MM replied with an evil smile: "Nope, I want to last few weak hands to fall off the tree. Rewards only come to those who wait".
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.